Evolution of carbapenemase activity in the class C β-lactamase ADC-1

ABSTRACT Antibiotic resistance in bacteria poses a significant threat to public health. Among dozens of available antimicrobial agents, carbapenems are used as drugs of choice for the treatment of serious infections caused by pathogens resistant to other antibiotics. However, their usefulness has be...

Full description

Saved in:
Bibliographic Details
Main Authors: Nichole K. Stewart, Marta Toth, Monolekha Bhattacharya, Clyde A. Smith, Sergei B. Vakulenko
Format: Article
Language:English
Published: American Society for Microbiology 2025-06-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.00185-25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850129415815561216
author Nichole K. Stewart
Marta Toth
Monolekha Bhattacharya
Clyde A. Smith
Sergei B. Vakulenko
author_facet Nichole K. Stewart
Marta Toth
Monolekha Bhattacharya
Clyde A. Smith
Sergei B. Vakulenko
author_sort Nichole K. Stewart
collection DOAJ
description ABSTRACT Antibiotic resistance in bacteria poses a significant threat to public health. Among dozens of available antimicrobial agents, carbapenems are used as drugs of choice for the treatment of serious infections caused by pathogens resistant to other antibiotics. However, their usefulness has been severely compromised due to the emergence and wide spread of carbapenem-resistant clinical isolates worldwide. High-level resistance to carbapenems in bacteria is mediated by the production of β-lactamases from three molecular classes, A, B, and D, but not by class C enzymes. In this study, we selected a triple mutant of the intrinsic class C Acinetobacter-derived cephalosporinase ADC-1 (ADC-1TM) that confers high-level resistance to the carbapenems meropenem, ertapenem, and doripenem. Kinetic experiments demonstrated that the apparent binding affinity, along with the acylation and deacylation rates, were all improved for the mutant enzyme. X-ray crystallography, molecular docking, and molecular dynamics simulations revealed that the amino acid substitutions in ADC-1TM produce significant changes in the enzyme active site architecture and binding mode of the carbapenem ertapenem. These changes allow for better positioning of a deacylating water for nucleophilic attack, thus explaining the significantly improved rate of ertapenem deacylation by ADC-1TM. In this study, we showed for the first time that a class C β-lactamase can produce high-level resistance to carbapenem antibiotics, which underlines the potential for enzymes of this class to evolve such resistance and could further exacerbate the problem of antibiotic resistance in bacteria.IMPORTANCECarbapenems belong to the most widely used family of β-lactam antibiotics and are considered drugs of choice for difficult-to-treat and often deadly infections. Widespread carbapenem-resistant isolates have drastically diminished the utility of these important antibiotics and resulted in high mortality rates. Resistance to carbapenems in clinical pathogens is mainly due to the production of β-lactamases, enzymes that destroy these drugs. Out of the four molecular classes of β-lactamases, various enzymes belonging to classes A, B, and D produce high levels of resistance to carbapenems; however, enzymes of class C have failed to evolve such resistance. Here, we demonstrate that the intrinsic ADC-1 β-lactamase of the clinically important pathogen Acinetobacter baumannii can evolve high-level resistance to carbapenems by just three amino acid substitutions and disclose the molecular mechanisms of its carbapenemase activity. This study demonstrates the potential for the evolution of carbapenemase activity in class C β-lactamases.
format Article
id doaj-art-0a9e1a2cd1d14f2b9acc5b059bdd3f09
institution OA Journals
issn 2150-7511
language English
publishDate 2025-06-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj-art-0a9e1a2cd1d14f2b9acc5b059bdd3f092025-08-20T02:33:00ZengAmerican Society for MicrobiologymBio2150-75112025-06-0116610.1128/mbio.00185-25Evolution of carbapenemase activity in the class C β-lactamase ADC-1Nichole K. Stewart0Marta Toth1Monolekha Bhattacharya2Clyde A. Smith3Sergei B. Vakulenko4Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USADepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USADepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USAStanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California, USADepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USAABSTRACT Antibiotic resistance in bacteria poses a significant threat to public health. Among dozens of available antimicrobial agents, carbapenems are used as drugs of choice for the treatment of serious infections caused by pathogens resistant to other antibiotics. However, their usefulness has been severely compromised due to the emergence and wide spread of carbapenem-resistant clinical isolates worldwide. High-level resistance to carbapenems in bacteria is mediated by the production of β-lactamases from three molecular classes, A, B, and D, but not by class C enzymes. In this study, we selected a triple mutant of the intrinsic class C Acinetobacter-derived cephalosporinase ADC-1 (ADC-1TM) that confers high-level resistance to the carbapenems meropenem, ertapenem, and doripenem. Kinetic experiments demonstrated that the apparent binding affinity, along with the acylation and deacylation rates, were all improved for the mutant enzyme. X-ray crystallography, molecular docking, and molecular dynamics simulations revealed that the amino acid substitutions in ADC-1TM produce significant changes in the enzyme active site architecture and binding mode of the carbapenem ertapenem. These changes allow for better positioning of a deacylating water for nucleophilic attack, thus explaining the significantly improved rate of ertapenem deacylation by ADC-1TM. In this study, we showed for the first time that a class C β-lactamase can produce high-level resistance to carbapenem antibiotics, which underlines the potential for enzymes of this class to evolve such resistance and could further exacerbate the problem of antibiotic resistance in bacteria.IMPORTANCECarbapenems belong to the most widely used family of β-lactam antibiotics and are considered drugs of choice for difficult-to-treat and often deadly infections. Widespread carbapenem-resistant isolates have drastically diminished the utility of these important antibiotics and resulted in high mortality rates. Resistance to carbapenems in clinical pathogens is mainly due to the production of β-lactamases, enzymes that destroy these drugs. Out of the four molecular classes of β-lactamases, various enzymes belonging to classes A, B, and D produce high levels of resistance to carbapenems; however, enzymes of class C have failed to evolve such resistance. Here, we demonstrate that the intrinsic ADC-1 β-lactamase of the clinically important pathogen Acinetobacter baumannii can evolve high-level resistance to carbapenems by just three amino acid substitutions and disclose the molecular mechanisms of its carbapenemase activity. This study demonstrates the potential for the evolution of carbapenemase activity in class C β-lactamases.https://journals.asm.org/doi/10.1128/mbio.00185-25class C carbapenemasecarbapenemantibiotic resistancecrystal structurekineticsAcinetobacter baumannii
spellingShingle Nichole K. Stewart
Marta Toth
Monolekha Bhattacharya
Clyde A. Smith
Sergei B. Vakulenko
Evolution of carbapenemase activity in the class C β-lactamase ADC-1
mBio
class C carbapenemase
carbapenem
antibiotic resistance
crystal structure
kinetics
Acinetobacter baumannii
title Evolution of carbapenemase activity in the class C β-lactamase ADC-1
title_full Evolution of carbapenemase activity in the class C β-lactamase ADC-1
title_fullStr Evolution of carbapenemase activity in the class C β-lactamase ADC-1
title_full_unstemmed Evolution of carbapenemase activity in the class C β-lactamase ADC-1
title_short Evolution of carbapenemase activity in the class C β-lactamase ADC-1
title_sort evolution of carbapenemase activity in the class c β lactamase adc 1
topic class C carbapenemase
carbapenem
antibiotic resistance
crystal structure
kinetics
Acinetobacter baumannii
url https://journals.asm.org/doi/10.1128/mbio.00185-25
work_keys_str_mv AT nicholekstewart evolutionofcarbapenemaseactivityintheclasscblactamaseadc1
AT martatoth evolutionofcarbapenemaseactivityintheclasscblactamaseadc1
AT monolekhabhattacharya evolutionofcarbapenemaseactivityintheclasscblactamaseadc1
AT clydeasmith evolutionofcarbapenemaseactivityintheclasscblactamaseadc1
AT sergeibvakulenko evolutionofcarbapenemaseactivityintheclasscblactamaseadc1